Dare Bioscience to Acquire Microchips Biotech

Daré may pay up to $46.5 million in contingent consideration for product development, regulatory and funding milestones and up to $55.0 million in contingent consideration for commercial development milestone

Benzinga · 11/11/2019 13:04

Daré may pay up to $46.5 million in contingent consideration for product development, regulatory and funding milestones and up to $55.0 million in contingent consideration for commercial development milestone payments, the amount of which will depend on the extent to which various milestones are achieved, as well as tiered royalty payments.  Daré expects that less than $1.3 million of the contingent consideration may become payable through 2021.